These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21765100)

  • 1. Different effects of corticotropin-releasing factor and urocortin 2 on apoptosis of prostate cancer cells in vitro.
    Jin L; Zhang Q; Guo R; Wang L; Wang J; Wan R; Zhang R; Xu Y; Li S
    J Mol Endocrinol; 2011 Oct; 47(2):219-27. PubMed ID: 21765100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity and regulation of extracellularly regulated kinase1/2 phosphorylation through corticotropin-releasing factor (CRF) receptors 1 and 2beta by the CRF/urocortin family of peptides.
    Brar BK; Chen A; Perrin MH; Vale W
    Endocrinology; 2004 Apr; 145(4):1718-29. PubMed ID: 14670995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticotropin-releasing hormone receptors mediate apoptosis via cytosolic calcium-dependent phospholipase A₂ and migration in prostate cancer cell RM-1.
    Jin L; Li C; Li R; Sun Z; Fang X; Li S
    J Mol Endocrinol; 2014 Jun; 52(3):255-67. PubMed ID: 24776847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urocortin 2 autocrine/paracrine and pharmacologic effects to activate AMP-activated protein kinase in the heart.
    Li J; Qi D; Cheng H; Hu X; Miller EJ; Wu X; Russell KS; Mikush N; Zhang J; Xiao L; Sherwin RS; Young LH
    Proc Natl Acad Sci U S A; 2013 Oct; 110(40):16133-8. PubMed ID: 24043794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of CRF and urocortins on the hippocampal glutamate release.
    Bagosi Z; Balangó B; Pintér D; Csabafi K; Jászberényi M; Szabó G; Telegdy G
    Neurochem Int; 2015 Nov; 90():67-71. PubMed ID: 26216727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of CREB and ERK phosphorylation through corticotropin-releasing factor receptors type 1 and 2 in AtT-20 and A7r5 cells.
    Kageyama K; Hanada K; Moriyama T; Imaizumi T; Satoh K; Suda T
    Mol Cell Endocrinol; 2007 Jan; 263(1-2):90-102. PubMed ID: 17027144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of corticotropin-releasing factor and the urocortins on hypothalamic gamma-amino butyric acid release--the impacts on the hypothalamic-pituitary-adrenal axis.
    Bagosi Z; Csabafi K; Jászberényi M; Telegdy G
    Neurochem Int; 2012 Mar; 60(4):350-4. PubMed ID: 22306347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticotropin-releasing factor and urocortin I activate CREB through functionally selective Gβγ signaling in hippocampal pyramidal neurons.
    Stern CM; Meitzen J; Mermelstein PG
    Eur J Neurosci; 2011 Sep; 34(5):671-81. PubMed ID: 21819464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping the CRF-urocortins system in human osteoarthritic and rheumatoid synovial fibroblasts: effect of vasoactive intestinal peptide.
    Pérez-García S; Juarranz Y; Carrión M; Gutiérrez-Cañas I; Margioris A; Pablos JL; Tsatsanis C; Gomariz RP
    J Cell Physiol; 2011 Dec; 226(12):3261-9. PubMed ID: 21360527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The involvement of altered corticotropin releasing factor receptor 2 expression in prostate cancer due to alteration of anti-angiogenic signaling pathways.
    Tezval H; Jurk S; Atschekzei F; Serth J; Kuczyk MA; Merseburger AS
    Prostate; 2009 Mar; 69(4):443-8. PubMed ID: 19058138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urocortin 1 and Urocortin 2 induce macrophage apoptosis via CRFR2.
    Tsatsanis C; Androulidaki A; Dermitzaki E; Charalampopoulos I; Spiess J; Gravanis A; Margioris AN
    FEBS Lett; 2005 Aug; 579(20):4259-64. PubMed ID: 16054139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of the urocortin homologues stresscopin (SCP) and stresscopin-related peptide (SRP) against hypoxia/reoxygenation injury in rat neonatal cardiomyocytes.
    Chanalaris A; Lawrence KM; Stephanou A; Knight RD; Hsu SY; Hsueh AJ; Latchman DS
    J Mol Cell Cardiol; 2003 Oct; 35(10):1295-305. PubMed ID: 14519439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of corticoptropin-releasing factor and the urocortins on striatal dopamine release induced by electrical stimulation-an in vitro superfusion study.
    Bagosi Z; Jászberényi M; Bujdosó E; Telegdy G
    Neurochem Res; 2006 Feb; 31(2):209-13. PubMed ID: 16518577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for hormone recognition by the Human CRFR2{alpha} G protein-coupled receptor.
    Pal K; Swaminathan K; Xu HE; Pioszak AA
    J Biol Chem; 2010 Dec; 285(51):40351-61. PubMed ID: 20966082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticotropin-releasing factor receptor subtypes mediating nutritional suppression of estrous behavior in Syrian hamsters.
    Seymour PL; Dettloff SL; Jones JE; Wade GN
    Am J Physiol Regul Integr Comp Physiol; 2005 Aug; 289(2):R418-R423. PubMed ID: 15831766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of corticotropin-releasing factor and urocortin 2/3 mRNA by leptin in hypothalamic N39 cells.
    Yamagata S; Kageyama K; Akimoto K; Watanuki Y; Suda T; Daimon M
    Peptides; 2013 Dec; 50():1-7. PubMed ID: 24083959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of vasoactive peptide urocortin 2 on hemodynamics in spontaneous hypertensive rat and the role of L-type calcium channel and CRFR2.
    Liu C; Liu X; Yang J; Duan Y; Yao H; Li F; Zhang X
    Pharmacol Rep; 2015 Apr; 67(2):394-8. PubMed ID: 25712670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of agonist- and antagonist-binding domains of human corticotropin-releasing factor receptors.
    Liaw CW; Grigoriadis DE; Lorang MT; De Souza EB; Maki RA
    Mol Endocrinol; 1997 Dec; 11(13):2048-53. PubMed ID: 9415408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac CRFR1 Expression Is Elevated in Human Heart Failure and Modulated by Genetic Variation and Alternative Splicing.
    Pilbrow AP; Lewis KA; Perrin MH; Sweet WE; Moravec CS; Tang WH; Huising MO; Troughton RW; Cameron VA
    Endocrinology; 2016 Dec; 157(12):4865-4874. PubMed ID: 27754786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of urocortin-induced hypophagia and weight loss by corticotropin-releasing factor receptor 1 deficiency in mice.
    Bradbury MJ; McBurnie MI; Denton DA; Lee KF; Vale WW
    Endocrinology; 2000 Aug; 141(8):2715-24. PubMed ID: 10919255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.